EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis

Anna Hjort, David Iggman, Fredrik Rosqvist

Clinical Nutrition · 2024-04 · 43 (4) · 915-925

DOI: 10.1016/j.clnu.2024.02.014 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Nutrition, 2024-04. Verfasst von Anna Hjort und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biological Engineering, Division of Food and Nutrition Science, Chalmers University of Technology, Kemivägen 10, 41296 Goth…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Prediabetic State. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Continuous glucose monitoring (CGM) provides data on short-term glycemic variability (GV). GV is associated with adverse outcomes in individuals with diabetes. Whether GV is associated with cardiometabolic risk in individuals without diabetes is unclear. We systematically reviewed the literature to assess whether GV is associated with cardiometabolic risk markers or outcomes in individuals without diabetes. METHODS: Searches were performed in PubMed/Medline, Embase and Cochrane from inception through April 2022. Two researchers were involved in study selection, data extraction and quality assessment. Studies evaluating GV using CGM for ≥24 h were included. Studies in populations with acute and/or critical illness were excluded. Both narrative synthesis and meta-analyzes were performed, depending on outcome. RESULTS: Seventy-one studies were included; the majority were cross-sectional. Multiple measures of GV are higher in individuals with compared to without prediabetes and GV appears to be inversely associated with beta cell function. In contrast, GV is not clearly associated with insulin sensitivity, fatty liver disease, adiposity, blood lipids, blood pressure or oxidative stress. However, GV may be positively associated with the degree of atherosclerosis and cardiovascular events in individuals with coronary disease. CONCLUSION: GV is elevated in prediabetes, potentially related to beta cell dysfunction, but less clearly associated with obesity or traditional risk factors. GV is associated with coronary atherosclerosis development and may predict cardiovascular events and type 2 diabetes. Prospective studies are warranted, investigating the predictive power of GV in relation to incident disease. GV may be an important risk measure also in individuals without diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDiabetes Mellitus, Type 2Prediabetic StateHumansBlood GlucoseBlood Glucose Self-MonitoringContinuous Glucose Monitoring

Stichwörter der Autor:innen

AtherosclerosisCardiovascular diseaseContinuous glucose monitoringGlycemic variabilityPrediabetesType 2 diabetes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Biology and Biological Engineering, Division of Food and Nutrition Science, Chalmers University of Technology, Kemivägen 10, 41296 Gothenburg, Sweden. Electronic address: anna.hjort@chalmers.se.
  • Center for Clinical Research Dalarna, Uppsala University, Nissers väg 3, 79182 Falun, Sweden; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Husargatan 3, BMC, Bo…
  • Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Husargatan 3, BMC, Box 564, 75122 Uppsala, Sweden. Electronic address: Fredrik.rosqvist@pubcare.uu.se.

Zitieren

APA

Hjort, A., Iggman, D., & Rosqvist, F. (2024). Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis. Clinical Nutrition, 43(4), 915-925. https://doi.org/10.1016/j.clnu.2024.02.014

Vancouver

Hjort A, Iggman D, Rosqvist F. Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis. Clinical Nutrition. 2024;43(4):915-925. doi:10.1016/j.clnu.2024.02.014

BibTeX
@article{Hjort2024,
  author = {Hjort, Anna and Iggman, David and Rosqvist, Fredrik},
  title = {Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis},
  journal = {Clinical Nutrition},
  year = {2024},
  volume = {43},
  number = {4},
  pages = {915--925},
  doi = {10.1016/j.clnu.2024.02.014}
}
Kostenlos starten →